BRIEF published on 03/10/2026 at 18:35, 11 days 10 hours ago Oxurion extends its financing program until 2027 Convertible Bonds Funding Extension Market Capitalization Oxurion
BRIEF published on 03/10/2026 at 18:35, 11 days 10 hours ago Oxurion étend son programme de financement avec Atlas Special Opportunities Obligations Convertibles Capitalisation Boursière Financement D'Oxurion Accord Atlas Échéance De L'obligation
BRIEF published on 03/10/2026 at 18:35, 11 days 10 hours ago Oxurion prolonge son programme de financement jusqu'à 2027 Financement Obligations Convertibles Capitalisation Boursière Oxurion Prolongation
PRESS RELEASE published on 03/10/2026 at 18:30, 11 days 10 hours ago Oxurion Extends Its Financing Program Oxurion NV extends financing program with Atlas Special Opportunities II, LLC. Amendments include 12-month extension, adjusted maturity terms, and right to transfer bonds internationally Biopharmaceutical Company Oxurion NV Financing Program Atlas Special Opportunities II LLC Bond Subscription Agreement
PRESS RELEASE published on 03/10/2026 at 18:30, 11 days 10 hours ago Oxurion verlengt haar financieringsprogramma Oxurion NV, ein belgisches Biofarmazieunternehmen, verlängert und modifiziert das Finanzierungsprogramm mit Atlas Special Opportunities II, LLC Finanzierung Oxurion Belgien Atlas Special Opportunities II, LLC Biofarmazie
PRESS RELEASE published on 03/10/2026 at 18:30, 11 days 10 hours ago Oxurion prolonge son programme de financement Oxurion NV prolonge son programme de financement d'obligations convertibles avec Atlas Special Opportunities II, LLC jusqu'au 2 mars 2027 et ajuste les conditions de financement Financement Obligations Convertibles Avenant Oxurion NV Atlas Special Opportunities II LLC
BRIEF published on 02/27/2026 at 18:05, 22 days 11 hours ago Oxurion continues discussions for the acquisition of a French CRO Acquisition Pharmaceutical Due Diligence Oxurion French CRO
BRIEF published on 02/27/2026 at 18:05, 22 days 11 hours ago Oxurion prolonge les négociations en vue de l'acquisition d'une CRO française Acquisition Biopharmaceutique Vérifications Nécessaires Oxurion CRO Français
BRIEF published on 02/27/2026 at 18:05, 22 days 11 hours ago Oxurion Extends Negotiations for French CRO Acquisition Acquisition Biopharmaceutical Due Diligence Oxurion French CRO
BRIEF published on 02/27/2026 at 18:05, 22 days 11 hours ago Oxurion continue les discussions pour l'acquisition d'une CRO française Acquisition Due Diligence Pharmaceutique Oxurion CRO Française
Published on 03/20/2026 at 13:30, 1 day 15 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 16 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 1 day 6 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 8 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 8 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 8 hours ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 9 hours ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 1 day 10 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 10 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 11 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 11 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
